Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The primary objective of this trial is to determine if adjuvant apalutamide in prostate cancer patients at high risk of developing subsequent metastatic disease results in prolonged biochemically recurrence-free survival after radical prostatectomy (RPE) in comparison to standard of care (SOC).
Epistemonikos ID: ad28bafe4512c55985e4ddc310e92aef91e07d57
First added on: May 07, 2024